Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glycemic control and diabetic complications.

S Strowig1, P Raskin

  • 1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235-8858.

Diabetes Care
|September 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of basal-bolus therapy varies with baseline 1,5-anhydroglucitol level in people with Type 2 diabetes: a post hoc analysis.

Diabetic medicine : a journal of the British Diabetic Association·2018
Same author

Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study).

Diabetes, obesity & metabolism·2016
Same author

AMG 151 (ARRY-403), a novel glucokinase activator, decreases fasting and postprandial glycaemia in patients with type 2 diabetes.

Diabetes, obesity & metabolism·2015
Same author

Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: a randomized trial.

Diabetes, obesity & metabolism·2011
Same author

Glycaemic control with liraglutide: the phase 3 trial programme.

International journal of clinical practice. Supplement·2010
Same author

Twice-daily and three-times-daily dosing of a repaglinide/metformin fixed-dose combination tablet provide similar glycaemic control.

Diabetes, obesity & metabolism·2009

Glycemic control

Area of Science:

  • Endocrinology
  • Genetics
  • Metabolic Diseases

Background:

  • The link between glycemic control and diabetic complications is not fully understood.
  • About 25% of individuals with diabetes do not develop complications, regardless of blood sugar levels.
  • Genetic factors may play a role in the development of diabetic complications.

Purpose of the Study:

  • To explore the relationship between glycemic control and diabetic complications.
  • To investigate the role of genetic factors in diabetic complications.
  • To determine the optimal glycemic control for preventing or stabilizing diabetic complications.

Main Methods:

  • Review of epidemiological studies and clinical trials.
  • Analysis of genetic factors such as HLA type and hypertension predisposition.

Related Experiment Videos

  • Evaluation of the impact of improved glycemic control on retinopathy, microalbuminuria, and nervous system function.
  • Main Results:

    • Improved glycemic control can stabilize early diabetic retinopathy, microalbuminuria, and nervous system function.
    • Near-normal blood sugar levels improve serum lipoprotein levels.
    • Genetic predisposition appears to influence the development of diabetic complications.

    Conclusions:

    • The precise degree of glycemic control needed to impact diabetic complications is unknown.
    • Achieving near-normal blood sugar levels carries risks like severe hypoglycemia and weight gain.
    • Further research is required to understand the interplay between genetic factors and glycemic control in diabetes management.